We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XMTR icon
501
Xometry
XMTR
$4.47B
$3.86M 0.04%
67,900
+31,000
+84% +$1.45M
BNED icon
502
Barnes & Noble Education
BNED
$435M
$3.84M 0.04%
16,000
+1,250
+8% +$334K
HBIO icon
503
Harvard Bioscience
HBIO
$27.6M
$3.84M 0.04%
149,826
-12,200
-8% -$404K
CYH icon
504
Community Health Systems
CYH
$382M
$3.81M 0.04%
1,771,742
+244,019
+16% +$808K
ONTF
505
DELISTED
ON24
ONTF
$3.8M 0.04%
432,000
-3,700
-0.8% -$35.4K
HALO icon
506
Halozyme
HALO
$9.88B
$3.8M 0.04%
96,000
TRST
507
Trustco Bank Corp NY
TRST
$953M
$3.79M 0.04%
120,651
-58,723
-33% -$1.95M
NSIT icon
508
Insight Enterprises
NSIT
$3.85B
$3.79M 0.04%
45,972
+6,811
+17% +$606K
SBR
509
Sabine Royalty Trust
SBR
$1.06B
$3.76M 0.04%
52,948
SPT icon
510
Sprout Social
SPT
$530M
$3.76M 0.04%
62,000
+6,000
+11% +$361K
CSCO icon
511
Cisco
CSCO
$443B
$3.76M 0.04%
94,000
PFBC icon
512
Preferred Bank
PFBC
$1.24B
$3.76M 0.04%
57,597
-403
-0.7% -$28.1K
USAP
513
DELISTED
Universal Stainless & Alloy
USAP
$3.74M 0.04%
525,587
LZB icon
514
La-Z-Boy
LZB
$1.64B
$3.71M 0.04%
164,165
-32,876
-17% -$873K
BRC icon
515
Brady Corp
BRC
$4.46B
$3.7M 0.04%
88,708
+69,155
+354% +$3.19M
CVSA
516
Covista Inc
CVSA
$4.55B
$3.69M 0.04%
101,135
-131,012
-56% -$5M
UPWK icon
517
Upwork
UPWK
$1.18B
$3.68M 0.04%
270,000
VRA icon
518
Vera Bradley
VRA
$98.7M
$3.67M 0.04%
1,218,803
-569,899
-32% -$2.3M
AIOT
519
PowerFleet Inc
AIOT
$537M
$3.64M 0.04%
1,181,734
INSP icon
520
Inspire Medical Systems
INSP
$1.47B
$3.63M 0.04%
20,488
-10,000
-33% -$2.01M
J icon
521
Jacobs Solutions
J
$16B
$3.63M 0.04%
40,500
BRK.B icon
522
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.6M 0.04%
13,500
DLO icon
523
dLocal
DLO
$4.29B
$3.59M 0.04%
175,000
+73,000
+72% +$1.94M
VLGEA icon
524
Village Super Market
VLGEA
$657M
$3.58M 0.04%
185,023
+35,456
+24% +$782K
AVD icon
525
American Vanguard Corp
AVD
$68.7M
$3.51M 0.04%
187,867
-7,001
-4% -$146K

Similar funds

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.